Sutro’s Commitment to Patients
The fight against cancer is all too familiar. The potential effectiveness and precision of Sutro’s clinical candidates may change the way patients battle cancer. The advancements Sutro has made with our CellFree technology and the ability to manufacture with rigorous GMP standards, is advancing treatment options for patients.
Clinical Trials
Sutro is currently advancing two wholly owned clinical-stage programs that are designed to provide patient benefits across multiple areas of unmet need.
Commitment To Patients
Sutro’s technology enables us to design and test complex molecules as potential next generation cancer treatments in a rapid cycle of weeks rather than months.
Compassionate Use Access
Sutro will consider providing individual patients compassionate use access to an investigational medicine outside of a clinical trial only when all criterias are met.
Thank You
Our Sutro team would like to express our heart-felt thanks to the patients, their families and health care providers for participating in our clinical studies.